GT
RENEU

Glenmede Trust’s Cartesian Growth Corporation II Unit RENEU Stock Holding History

Glenmede Trust’s Portfolio RENEU Stock Details RENEU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-129,990
Closed -$1.3M – 1410
2022
Q2 		$1.3M Buy
+129,990
New +$1.3M 0.01% 610

Other funds holding RENEU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
AMH
Apollo Management Holdings New York $8.94B AUM 120.19% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
AC
Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Glenmede Trust's RENEU Position: Q3 2022 in Review

Glenmede Trust sold out of Cartesian Growth Corporation II Unit (RENEU) in Q3 2022, closing a stake of 129,990 shares — an estimated $1.3M sold.

Glenmede Trust first reported a position in RENEU in Q2 2022 and held it in 1 quarter. The position peaked at $1.3M in Q2 2022. 18 funds tracked by Wall St. Rank hold RENEU as of Q3 2022.

  • Glenmede Trust reported no remaining Cartesian Growth Corporation II Unit position as of Q3 2022 after selling out during the quarter.
  • Glenmede Trust sold 129,990 Cartesian Growth Corporation II Unit shares in Q3 2022, an estimated $1.3M.
  • Glenmede Trust first reported a position in Cartesian Growth Corporation II Unit in Q2 2022 and held it in 1 quarter.
  • Glenmede Trust's Cartesian Growth Corporation II Unit position peaked at $1.3M in Q2 2022.
  • 18 funds tracked by Wall St. Rank held Cartesian Growth Corporation II Unit as of Q3 2022.

Based on Glenmede Trust's 13F filing for Q3 2022, filed 16 Nov 2022.